41 Results for "

CHF

" in MedChemExpress (MCE) Product Catalog:
Products (41)

41 Results for "CHF" in MCE Product Catalog:

7
7 Publications Verification
Cat. No.: HY-B0205
CAS No.: 139481-59-7
Synonyms: CV 11974
Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14399
CAS No.: 749269-83-8
Purity:  99.37%
Synonyms: CHF5074; CSP-1103
Target:  

γ-secretase Apoptosis

Research Areas:  

Neurological Disease

Itanapraced (CHF5074) is an orally active γ-secretase modulator and a non-steroidal anti-inflammatory derivative. Itanapraced reduces Aβ42 and Aβ40 secretion with IC50 values of 3.6 and 18.4 μM, respectively. Itanapraced inhibits cell apoptosis of hippocampal neurons induced by oxygen and glucose deprivation (OGD). Itanapraced can be used for the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-B0592
CAS No.: 87679-37-6
Synonyms: RU44570
Trandolapril (RU44570) is a nonsulfhydryl proagent that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of hypertension and congestive heart failure (CHF), and after myocardial infarction (MI) .
loading...
    loading...
Cat. No.: HY-19929
CAS No.: 1239278-59-1
Synonyms: CHF-6001
Tanimilast (CHF-6001) is an orally active and selective phosphodiesterase 4 inhibitor (IC50=0.026 nM) with robust anti-inflammatory activity and suitable for topical pulmonary administration. Tanimilast increases cellular cAMP levels, and inhibits NF-κB signaling pathway. Tanimilast is used for the research of obstructive lung diseases .
loading...
    loading...
Cat. No.: HY-118472
CAS No.: 86541-78-8
Purity:  99.54%
Synonyms: CGS 14831
Benazeprilat is an orally active and the active metabolite of benazepril, a carboxyl-containing ACE inhibitor with antihypertensive activity. Benazepril is a well-established antihypertensive agent, both in monoresearch and in combination with other classes of drugs including thiazide diuretics and calcium channel blockers. Benazepril is a first-line research in reducing various pathologies associated with CV risk and secondary end-organ damage .
loading...
    loading...
Cat. No.: HY-123348
CAS No.: 129981-36-8
Purity:  99.22%
Synonyms: UK-81252
Sampatrilat (UK-81252) is a potent and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase (NEP). Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM). Sampatrilat (UK-81252) can be used for the study of chronic heart failure and blood pressure regulation .
loading...
    loading...
Cat. No.: HY-151198
CAS No.: 1615208-41-7
CHF-6366 is a potent M3 muscarinic antagonist and β2-adrenergic receptors agonist with pKi values of 10.4 and 11.4, respectively. CHF-6366 is also a weak calcium channel inhibitor (IC50~50 μM). CHF-6366 inhibits bronchoconstriction in guinea pigs. CHF-6366 can be used to research chronic obstructive pulmonary disease (COPD) .
loading...
    loading...
Cat. No.: HY-120577
CAS No.: 166020-57-1
Target:  

Others

Research Areas:  

Cardiovascular Disease

BA 41899 is a purely calcium-sensitizing agent. BA 41899 is completely devoid of phosphodiesterase (PDE) III inhibitory activity or any other known inotropic mechanism. BA 41899 can be used for the research of cardiovascular diseases, such as congestive heart failure (CHF) .
loading...
    loading...
Cat. No.: HY-106994A
CAS No.: 342005-82-7
Purity:  98.30%
Synonyms: YM598
Nebentan potassium (YM598) is a potent, selective and orally active non-peptide endothelin ETA receptor antagonist through the modification of Bosentan (HY-A0013). Nebentan potassium inhibits [ 125I] endothelin-1 binding to cloned human endothelin ETA and ETB receptor, with Ki of 0.697 nM and 569 nM, respectively . YM598 can ameliorate the progression of cor pulmonale and myocardial infarction in vivo .
loading...
    loading...
Cat. No.: HY-U00302
CAS No.: 1004312-94-0
Target:  

mAChR

Research Areas:  

Inflammation/Immunology

CHF5407 is a selective, long-acting and competitive muscarinic M3 receptor antagonist. CHF5407 shows subnanomolar affinities for human muscarinic M1 (hM1), M2 (hM2) and M3 (hM3) receptors. CHF5407 shows a prolonged antibronchospastic activity .
loading...
    loading...
Cat. No.: HY-B0205R
CAS No.: 139481-59-7
Synonyms: CV 11974 (Standard)
Candesartan (Standard) is the analytical standard of Candesartan. This product is intended for research and analytical applications. Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI) .
loading...
    loading...
Cat. No.: HY-163702
CAS No.: 3052116-62-5
Research Areas:  

Inflammation/Immunology

CHF-6550 is an antagonist for muscarinic M3 receptor and an agonist for β2 adrenoceptor (MABA), with pKi of 9.3 and 10.6, respectively. CHF-6550 exhibits good hepatocyte clearance in rat models and good pharmacokinetic characteristics in guinea pigs .
loading...
    loading...
Cat. No.: HY-B0205S
CAS No.: 1346604-70-3
Synonyms: CV-11974-d4
Candesartan-d4 (CV-11974-d4) is the deuterium labeled Candesartan (HY-B0205). Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI).
loading...
    loading...
Cat. No.: HY-162878
CAS No.: 2500579-21-3
Target:  

PI3K

Research Areas:  

Inflammation/Immunology

CHF-6523 is an orally active PI3Kδ inhibitor that can be used in research related to chronic obstructive pulmonary disease (COPD) .
loading...
    loading...
Cat. No.: HY-123228
CAS No.: 749269-77-0
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

CHF5022 is an inhibitor of Aβ42 secretion (IC50=92 μM). CHF5022 retains a modest activity on Aβ40 at non-cytotoxic concentrations (−22.2±4.8% at 100 μM) .
loading...
    loading...
Cat. No.: HY-19929A
Synonyms: (R)-CHF-6001
Research Areas:  

Inflammation/Immunology

(R)-Tanimilast is a isomeride of Tanimilast (HY-19929). Tanimilast (CHF-6001) is a novel highly potent and selective phosphodiesterase 4 inhibitor (IC50=0.026 nM) .
loading...
    loading...
Cat. No.: HY-107045
CAS No.: 444643-64-5
Target:  

Estrogen Receptor/ERR

Research Areas:  

Endocrinology

CHF 4227 free base is an orally active and selective estrogen receptor modulator (SERM) with high affinity to the human estrogen receptor-α and -β (Ki values of 0.017 nM and 0.099 nM, respectively) .
loading...
    loading...
Cat. No.: HY-101440A
CAS No.: 202914-18-9
Synonyms: CHF-3381
Target:  

iGluR Monoamine Oxidase

Research Areas:  

Neurological Disease

Indantadol hydrochloride (CHF-3381) is an orally active, non-selective NMDA antagonist and MAO inhibitor. Indantadol hydrochloride blocks the binding of [³H]-MK-801 to NMDA receptors in a non-competitive manner, with an IC50 of 8.1 μM. Indantadol hydrochloride completely inhibits dopamine release caused by NMDA. Indantadol hydrochloride protects neurons, with an ED₅₀ of 35 μM. Indantadol hydrochloride has anticonvulsant and anti-high pain hypersensitivity activities .
loading...
    loading...
Cat. No.: HY-106973A
CAS No.: 138531-51-8
Synonyms: CHF 1035
Nolomirole (CHF 1035) hydrochloride is an orally active and selective DA2 dopaminergic receptor/α2-adrenoceptor agonist. Nolomirole attenuates the heart failure signs in the Monocrotaline (HY-N0750)-induced congestive heart failure model. Nolomirole increases cardiac output .
loading...
    loading...
Cat. No.: HY-118928
CAS No.: 412044-92-9
Synonyms: Demethyl-CHF 2819
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

Demethyl-Ganstigmine hydrochloride (Demethyl-CHF 2819) is an orally active AChE inhibitor. Demethyl-Ganstigmine hydrochloride promotes the release of sAPPα from neuroblastoma cells. Demethyl-Ganstigmine hydrochloride increases the concentration of acetylcholine in the prefrontal cortex of rats. Demethyl-Ganstigmine hydrochloride is used in research on neurological diseases such as Alzheimer's disease .
loading...
    loading...